Low AZT activity against HIV-2 infection
29 July 2004. Related: Conference reports, Drug resistance.
2004
No evidence for cross resistance between nevirapine and d4T
29 July 2004. Related: Conference reports, Drug resistance.
Experimental compounds to target viral expression in latent cells
29 July 2004. Related: Conference reports, Antiretrovirals, Drug resistance.
Case of MDR reinfection with MDR virus
29 July 2004. Related: Conference reports, Drug resistance.
Keystone HIV Pathogenesis and Vaccine Development Report 12-18 April 2004, Whistler, British Columbia, Canada
29 July 2004. Related: Conference reports.
Keystone HIV Pathogenesis and Vaccine Report
29 July 2004. Related: Conference reports, Basic science and immunology, Vaccines and microbicides.
A round-up of news about access to treatments, with links to sources
29 July 2004. Related: Treatment alerts.
CD4 entry criteria dropped for UK tipranavir named patient access
29 July 2004. Related: Antiretrovirals.
Tenofovir/FTC co-formulation expected in US by September
29 July 2004. Related: Antiretrovirals.
Guidelines for T-20
29 July 2004. Related: Antiretrovirals.
Persistent HIV viraemia fosters immunologic harm and viral evolution
29 July 2004. Related: Antiretrovirals.
Latent drug-resistant HIV harboured for years
29 July 2004. Related: Antiretrovirals.
Non-prescription simvastatin in the UK: contraindicated with many HIV medications
29 July 2004. Related: PK and drug interactions.
Label changes for indinavir warn of several interactions including atazanavir and PDE5 inhibitors
29 July 2004. Related: PK and drug interactions.
Smoking during HIV infection may alter the natural history of HPV infection and increase the risk of cervical disease
29 July 2004. Related: Women's health.
Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with HIV
29 July 2004. Related: Paediatric care.
Sexual transmission of HIV by acutely infected individuals has a disproportionate effect on the spread of HIV and may explain the current pandemic
29 July 2004. Related: HIV prevention and transmission.
Online medical resources
29 July 2004. Related: On the web.
Conference abstracts
29 July 2004. Related: On the web.
Treatment Access
29 July 2004. Related: On the web.
Journal articles
29 July 2004. Related: On the web.
Online publications
29 July 2004. Related: On the web.
Volume 5 Number 6 July 2004 PDF
1 July 2004. Related: PDFs.
Volume 5 Number 5 June 2004
2 June 2004. Related: Editorial.
10th Anniversary Conference of the British HIV Association (BHIVA), 15–17 April 2004, Cardiff
2 June 2004. Related: Conference reports.
BHIVA 2003-4 audit on HIV and pregnancy
2 June 2004. Related: Conference reports.
More positive children are surviving into adult life and require tailored services
2 June 2004. Related: Conference reports, Paediatric care.
Other news from 10th BHIVA conference
2 June 2004. Related: Conference reports.
Antiviral activity of foscarnet in salvage therapy
2 June 2004. Related: Antiretrovirals.
Kaletra therapy fails woman with subtype C virus with multiple mutations
2 June 2004. Related: Drug resistance.
Oral uridine to treat mitochondrial toxicity
2 June 2004. Related: Side effects.
Phase II results show ThGRF could be safe, effective treatment for lipodystrophy, says company
2 June 2004. Related: Side effects, Lipodystrophy and metabolic complications.
Reversibility of lipoatrophy in HIV patients 2 years after switching from a thymidine analogue to abacavir
2 June 2004. Related: Side effects, Lipodystrophy and metabolic complications.
Rapid clearance of HIV-1 is associated with decreased risk of AIDS
2 June 2004. Related: Basic science and immunology.
HIV patients get long-term boost with short, intermittent drug regimen
2 June 2004. Related: Basic science and immunology.
The 39th Annual Meeting of the European Association for the Study of the Liver (39th EASL)
2 June 2004. Related: Hepatitis coinfection.
Tenofovir blocks viral replication in HBV monoinfected and in HIV-HBV coinfected patients with lamivudine resistance
2 June 2004. Related: Hepatitis coinfection.
Compared to Caucasians, Africans have significantly higher rates of fibrosis and cirrhosis despite lower levels of HBV replication
2 June 2004. Related: Hepatitis coinfection.
Undetectable HIV viral load in HIV-HCV coinfected patients slows liver fibrosis progression rate
2 June 2004. Related: Hepatitis coinfection.
US government stops scientists attending International AIDS Conference
2 June 2004. Related: Other news.
EMEA releases recommendations for better information for patients
2 June 2004. Related: Other news.
Response to report from 11th CROI on treatment in primary infection
2 June 2004. Related: Correspondence.
Conference abstracts
2 June 2004. Related: On the web.
Treatment access
2 June 2004. Related: On the web.
Journal articles
2 June 2004. Related: On the web.
Online medical resources
2 June 2004. Related: On the web.
Online publications
2 June 2004. Related: On the web.
Volume 5 Number 5 June 2004 PDF
1 June 2004. Related: PDFs.
Volume 5 Number 4 May 2004
2 May 2004. Related: Editorial.
5th International Workshop on Clinical Pharmacology of HIV Therapy, 1-3 April 2004, Rome, Italy
2 May 2004. Related: Conference reports, PK and drug interactions.
Large reductions in plasma PK levels of saquinavir, amprenavir and lopinavir/r levels when given with tipranavir/ritonavir
2 May 2004. Related: Conference reports, PK and drug interactions.
Good generic drugs and good adherence in Rwanda
2 May 2004. Related: Conference reports, Treatment access, PK and drug interactions.
Steady state PK of nelfinavir and M8 in pregnancy
2 May 2004. Related: Conference reports, Pregnancy, PK and drug interactions, TB coinfection.
Higher nelfinavir concentrations improve response in children
2 May 2004. Related: Conference reports, Paediatric care, PK and drug interactions.
PK of once daily lopinavir/r in children
2 May 2004. Related: Conference reports, Paediatric care, PK and drug interactions.
2nd European HIV Drug Resistance Workshop, 11-13 March 2004, Rome, Italy
2 May 2004. Related: Conference reports.
Understanding developments in HIV drug resistance for new drugs and targets — atazanavir, fusion (T-20) and receptor inhibitors
2 May 2004. Related: Conference reports, Drug resistance.
11th Conference on Retroviruses and Opportunistic Infections (CROI), 8-11 February 2004, San Francisco
2 May 2004. Related: Conference reports.
HIV-associated dementia and cognitive dysfunction
2 May 2004. Related: Conference reports, Coinfections and complications.
Diabetes and HIV and HCV; aging/HIV and diabetes
2 May 2004. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Outcomes after two years of providing antiretrovirals in Khayelitsha, South Africa
2 May 2004. Related: Treatment access.
A round-up of news on access to treatments
2 May 2004. Related: Treatment access.
US treatment guidelines updated – March 2004
2 May 2004. Related: Antiretrovirals.
Atazanavir launched in UK
2 May 2004. Related: Antiretrovirals.
Tenofovir/FTC co-formulation application made to EMEA
2 May 2004. Related: Antiretrovirals.